(NASDAQ: CGNX) Cognex's forecast annual revenue growth rate of 8.76% is forecast to beat the US Scientific & Technical Instruments industry's average forecast revenue growth rate of 7.09%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.13%.
Cognex's revenue in 2026 is $1,046,760,000.On average, 25 Wall Street analysts forecast CGNX's revenue for 2026 to be $187,887,560,179, with the lowest CGNX revenue forecast at $170,579,937,275, and the highest CGNX revenue forecast at $202,366,052,416. On average, 25 Wall Street analysts forecast CGNX's revenue for 2027 to be $204,529,505,279, with the lowest CGNX revenue forecast at $180,731,523,786, and the highest CGNX revenue forecast at $221,005,030,928.
In 2028, CGNX is forecast to generate $225,331,936,654 in revenue, with the lowest revenue forecast at $202,199,632,965 and the highest revenue forecast at $247,632,143,088.